Vanqua Bio
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $85M
Investors
- 9
About Vanqua Bio
Founded in 2019 and based in Illinois, US, Vanqua Bio operates as a biopharmaceutical company that develops and discovers treatments for neurodegenerative diseases. The company was co-founded by Dr. Dimitri Krainc and Dr. James Sullivan. The company operates Vanqua Bio, a technology platform that utilizes human genetics and patient-derived neuronal cells to identify, validate, and clinically translate novel disease pathways associated with lysosomal dysfunction of the immune system. The company's program targets glucocerebrosidase (GCase) as a treatment for Parkinson’s disease (PD) and all forms of Gaucher disease or lysosomal storage disorder. Additional programs address the overactivation of the innate immune system in central and peripheral neurodegenerative disorders, including ALS and Alzheimer’s disease.
Who invested in Vanqua Bio
9 investors across 1 round
See all investors in Vanqua Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 27, 2021
Amount
$85M
Investors
Questions about Vanqua Bio
Who invested in Vanqua Bio?
Vanqua Bio has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vanqua Bio raised?
Vanqua Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vanqua Bio last raise money?
Vanqua Bio's most recent round on record is a Series B, in Aug 2021.
What does Vanqua Bio do?
Founded in 2019 and based in Illinois, US, Vanqua Bio operates as a biopharmaceutical company that develops and discovers treatments for neurodegenerative diseases.
Where is Vanqua Bio headquartered?
Vanqua Bio is headquartered in Chicago, US.
Which VCs invest in companies like Vanqua Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vanqua Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Vanqua Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.